MedTrace Logo

Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital

NCT04161521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-11-13

No results posted yet for this study

Summary

Evaluation of maternal morbidity and mortality of our novel surgical procedure for conservative management of placenta accreta in our tertiary referral institute.

Conditions

  • Placenta Accreta

Interventions

PROCEDURE

Novel Technique of Placenta Accreta in Menoufia University Hospital

* Classical CS to decrease haemorrhage from placental bed. * Delievery of the fetus. * At the delivery 10 UI of oxytocin IV will be injected. * The placenta is not attempted to be delievered. * Opening of the broad ligament via round ligament division and ligation. * Gentle dissection of the urinary bladder from lateral to medial. * Bilateral uterine artery clamping at low level below the placental bed . * Gentle attempt to deliver The placenta. * If the placenta is delievered we will do bilateral uterine artery ligation at multiple levels and multiple square compression sutures(if needed) for proper hemeostasis at the placental bed. Then closure of uterine incision. * If the placenta is not delievered we will do segmental ressection of lower uterine segment including the placenta . * Intraperitoneal drain insertion.

Sponsors & Collaborators

  • Menoufia Obstetrics and Gynecology Group

    lead OTHER

Principal Investigators

  • Hamed E Ellakwa · Menoufia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-11-01
Completion
2019-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04161521 on ClinicalTrials.gov